...
首页> 外文期刊>Media of Health Research and Development >UJI DISOLUSI DAN PENETAPAN KADAR TABLET LORATADIN INOVATOR DAN GENERIK BERMEREK
【24h】

UJI DISOLUSI DAN PENETAPAN KADAR TABLET LORATADIN INOVATOR DAN GENERIK BERMEREK

机译:溶液测试和品牌通用和洛拉丁片剂条件测试

获取原文
           

摘要

Antihistamines Loratadin available in tablet form, as loratadin tablets innovator, branded generic preparations. Socializing generic drugs need information about quality of these drugs, to ensure that the quality of generic drugs not lower or similar to its innovator drugs. The impact of economic crisis caused the price of very expensive drugs. The information quality of generic drugs is expected to increase the use of generic drugs by health practitioners and public. It is necessary for the laboratory data that are qualityparameters, such as dissolution profiles, dissolution testing and determinationof drug dosage levels. Dissolution test method anddetermination of levelsconducted in accordanceto the requirements of the USP (United State of Pharmacopeia). Loratadin dissolution test resultsof tablets A, B and Cin accordancewith the requirements of the USP. Loratadin contentin tablet Ais 103, 73%, B=99,62% and C=100,21%. Loratadin levels in all of these tablets meet the requirements of the USP. Key words: innovator,branded generic drug, dissolution, content
机译:抗组胺药Loratadin以片剂形式提供,是loratadin片剂的创新者,是品牌的通用制剂。使仿制药社会化需要有关这些药物质量的信息,以确保仿制药的质量不低于其创新药物或与其创新药物不相近。经济危机的影响导致非常昂贵的药品价格上涨。预计仿制药的信息质量将增加卫生从业者和公众对仿制药的使用。对于作为质量参数的实验室数据来说是必要的,例如溶出曲线,溶出度测试和药物剂量水平的确定。溶出度测试方法和含量测定按照美国药典(USP)的要求进行。符合美国药典要求的片剂A,B和Cin的洛拉他丁溶出度测试结果。片剂Ais中洛拉丁的含量为103%,73%,B = 99.62%和C = 100.21%。所有这些片剂中的洛拉丁水平均符合美国药典的要求。关键词:创新者品牌仿制药溶出度含量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号